1. A patent review of FGFR4 selective inhibition in cancer (2007-2018). (3rd June 2019) Authors: Quintanal-Villalonga, Alvaro; Ferrer, Irene; Molina-Pinelo, Sonia; Paz-Ares, Luis Journal: Expert opinion on therapeutic patents Issue: Volume 29:Number 6(2019) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to "Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer". (8th July 2018) Authors: Marrugal, Ángela; Ojeda, Laura; Paz-Ares, Luis; Molina-Pinelo, Sonia; Ferrer, Irene Journal: Disease markers Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective. (May 2019) Authors: Quintanal-Villalonga, Alvaro; Molina-Pinelo, Sonia; Yagüe, Patricia; Marrugal, Ángela; Ojeda-Márquez, Laura; Suarez, Rocío; Ponce-Aix, Santiago; Enguita, Ana Belén; Carnero, Amancio; Ferrer, Irene; Paz-Ares, Luis Journal: Lung cancer Issue: Volume 131(2019) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. KRAS-Mutant non-small cell lung cancer: From biology to therapy. (October 2018) Authors: Ferrer, Irene; Zugazagoitia, Jon; Herbertz, Stephan; John, William; Paz-Ares, Luis; Schmid-Bindert, Gerald Journal: Lung cancer Issue: Volume 124(2018) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Osimertinib in EGFR-mutant NSCLC: how to select patients and when to treat. Issue 12 (December 2016) Authors: Zugazagoitia, Jon; Ferrer, Irene; Paz-Ares, Luis Journal: Lancet oncology Issue: Volume 17:Issue 12(2016:Dec.) Page Start: 1622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer. (30th June 2016) Authors: Marrugal, Ángela; Ojeda, Laura; Paz-Ares, Luis; Molina-Pinelo, Sonia; Ferrer, Irene Other Names: Neagu Monica Academic Editor. Journal: Disease markers Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB2 harmonization project comparing three NGS panels. Issue 5 (7th May 2021) Authors: Ramos-Paradas, Javier; Hernández-Prieto, Susana; Lora, David; Sanchez, Elena; Rosado, Aranzazu; Caniego-Casas, Tamara; Carrizo, Nuria; Enguita, Ana Belén; Muñoz-Jimenez, María Teresa; Rodriguez, Borja; Perez-Gonzalez, Urbicio; Gómez-Sánchez, David; Ferrer, Irene; Ponce Aix, Santiago; Nuñez Buiza,... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tunable gold nanorod/NAO conjugates for selective drug delivery in mitochondria-targeted cancer therapy. Issue 22 (26th May 2022) Authors: González-Rubio, Sergio; Salgado, Cástor; Manzaneda-González, Vanesa; Muñoz-Úbeda, Mónica; Ahijado-Guzmán, Rubén; Natale, Paolo; Almendro-Vedia, Víctor G.; Junquera, Elena; Barcina, José Osío; Ferrer, Irene; Guerrero-Martínez, Andrés; Paz-Ares, Luis; López-Montero, Iván Journal: Nanoscale Issue: Volume 14:Issue 22(2022) Page Start: 8028 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications. (26th July 2016) Authors: Quintanal-Villalonga, A.; Paz-Ares, Luis; Ferrer, Irene; Molina-Pinelo, S. Other Names: Neagu Monica Academic Editor. Journal: Disease markers Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗